基于金属有机框架的药物输送系统的进步,用于cuproptosis介导的癌症治疗
Haodong Ruan1, Yenuo Chen1, Junlin Qian2
1Dongguan Key Laboratory of Drug Design and Formulation Technology, School of Pharmacy, Guangdong Medical University, Dongguan 523808, China.
概括
金属有机框架 (MOFs) 通过实现向药物输送,为癌症治疗提供了一个有前途的平台. 将MOF与cuproptosis结合起来,这是一个新的细胞死亡途径,为有效的瘤干预提供了一个新的策略.
科学领域:
- 纳米材料科学科学 纳米材料科学
- 在瘤学瘤学.
- 生物化学 生物化学
背景情况:
- 癌症仍然是全球死亡的主要原因,目前的诊断和治疗方法在敏感性,特异性和毒性方面面临限制.
- 金属有机框架 (MOF) 是多功能纳米材料,具有适用于药物输送的调节性质.
- cuproptosis 是一种依赖铜的受调节细胞死亡途径,已成为瘤学的新治疗点.
研究的目的:
- 审查最近在将MOF与基于cuproptosis的癌症疗法的整合方面的进展.
- 要突出设计策略,机械洞察力和MOF介导的cuproptosis的治疗应用.
- 确定临床翻译的挑战和未来方向.
主要方法:
- 关于MOFs,cuproptosis及其在癌症治疗中的交叉点研究的文献综述.
- 对影响瘤向和药物释放的MOF物理化学性质的分析.
- 检查cuproptosis的分子机制及其诱导的MOF-based代理.
主要成果:
- 可以通过颗粒设计和表面功能化来设计MOF来增强瘤积累和细胞吸收.
- MOFs可以作为携带铜离子或诱导cuproptosis的药物的载体.
- 用MOF向cuproptosis显示了选择性杀死癌细胞的潜力,并降低了全身毒性.
结论:
- MOFs和cuproptosis的组合代表了开发下一代癌症疗法的有希望的战略.
- 需要进一步的研究来解决临床应用的药理动力学,生物安全性和翻译性挑战.
- 优化MOF设计和有针对性的交付对于最大限度地提高治疗疗效和患者的结果至关重要.
相关概念视频
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
17
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
17
01:24Modified-Release Drug Delivery Systems: Site-Targeted
18
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
18
01:23Ophthalmic Drug Delivery Systems
27
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
27
01:19Modified-Release Drug Delivery Systems: Overview
17
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
17
01:27Drug Delivery Systems: Different Types
16
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
16
01:15Drugs that Stabilize Microtubules
2.8K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.8K